Thursday, March 07, 2024 3:19:57 PM
Quikshft - Coretec currently has about 285 million shares of common stock issued. In the share exchange agreement it looks like 705,561,076 more common shares will be issued. The 10 million series C preferred stock converts to another 1.5 billion shares. With an approved OS of 1.5 billion, how is this possible?
ChatGPT
Thank you for providing the additional context. Based on the information you've provided, it appears that the issuance of shares outlined in the share exchange agreement would indeed exceed Coretec's authorized share count of 1.5 billion shares.
Here's a breakdown of the potential share issuances:
Common Stock: The share exchange agreement mentions the issuance of 705,561,076 shares of Coretec's common stock to the members of Core Optics.
Series C Preferred Stock: Additionally, the agreement states the issuance of 10 million shares of Series C Convertible Preferred Stock, which are convertible into another 1.5 billion shares of common stock.
Adding these two together:
705,561,076 (Common Stock) + 1,500,000,000 (Common Stock from Series C Preferred Stock) = 2,205,561,076
This total exceeds Coretec's authorized share count of 1.5 billion shares.
If Coretec wishes to proceed with these issuances, it would likely need to take steps to increase its authorized share count. This typically involves obtaining approval from its shareholders to amend its articles of incorporation or similar corporate governance documents to authorize the issuance of additional shares.
Recent CRTG News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 01:30:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/08/2024 01:31:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/08/2024 01:30:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 09:01:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 03:07:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 02:51:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 06:06:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:43:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:41:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:40:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 10:38:33 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/31/2023 08:36:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 12:24:21 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM